UK Carrier Screening Market (2023-2028)
The UK Carrier Screening Market was valued at $140.2 Million in 2023 and projected to reach to $339 Million by 2028, representing a compound annual growth rate of 19.3%. The UK carrier screening market is positioned for substantial growth over the forecast period, driven by increasing adoption of advanced genetic testing technologies and heightened awareness among UK patients and healthcare providers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Carrier Screening Market Trends and Insights
- The UK market is driven by increasing awareness of genetic disorders, advances in DNA sequencing technology, and growing adoption of non-invasive prenatal testing among UK healthcare providers and patients.
- The UK's robust National Health Service infrastructure and emphasis on preventive medicine continue to support market expansion. In the UK, carrier screening adoption is accelerating due to expanded NHS guidelines recommending genetic testing for at-risk populations and improved accessibility to testing services across UK clinics and hospitals.
- The UK market benefits from strong regulatory frameworks, including oversight by the Human Fertilisation and Embryology Authority, which ensures quality and safety standards.
- Between 2023 and 2028, the UK is expected to see significant growth in both public and private sector carrier screening initiatives, driven by technological innovation and rising consumer demand for personalized reproductive health solutions..
Key Market Statistics
- CAGR (2023-2028) 19.3% CAGR
- Market Size, 2023 ~USD 140.2 Million
- Forecast, 2028 ~USD 339 Million
- Country UK
UK Carrier Screening Market Overview
Market Valuation Growth :
The UK carrier screening market reached £140.2 million in 2023 and is forecast to grow to £339.0 million by 2028, driven by a robust 19.3% CAGR, outpacing many European counterparts.
NHS Integration & Adoption :
Increasing integration of carrier screening into NHS prenatal pathways and expanded access to non-invasive prenatal testing (NIPT) across UK healthcare providers is accelerating market penetration and patient uptake.
Genetic Awareness & Policy Support :
Rising public awareness of genetic disorders, coupled with supportive UK government policies on reproductive health and genetic testing, is creating favorable conditions for market expansion.
Technology Advancement :
Rapid advances in DNA sequencing technology and cost reduction in genetic testing are making carrier screening more accessible and affordable across UK private and public healthcare sectors.
UK Carrier Screening Market Dynamics
- NHS initiatives promoting preventive genetic screening and the expansion of non-invasive prenatal testing services are key growth catalysts.
- The market will benefit from declining sequencing costs, improved test accuracy, and growing integration into standard prenatal care protocols across England, Scotland, Wales, and Northern Ireland. Looking ahead, the UK market is expected to see increased competition among diagnostic laboratories and genetic testing providers, alongside regulatory developments from the Human Fertilisation and Embryology Authority (HFEA).
- Strategic partnerships between NHS trusts and private genetic testing companies, combined with patient education campaigns, will further drive market penetration.
- The shift towards personalized medicine and preventive healthcare in the UK will solidify carrier screening as a standard component of reproductive health services..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The UK carrier screening market is valued at £140.2 million in 2023 and will reach £339.0 million by 2028, growing at 19.3% CAGR.
- NHS integration and expanded genetic testing guidelines are key drivers of carrier screening adoption across the UK.
- The UK market benefits from strong regulatory oversight and a well-established healthcare infrastructure supporting genetic testing services.
- Technological advances in DNA sequencing and non-invasive prenatal testing are accelerating market growth in the UK between 2023 and 2028.
Carrier Screening Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | PULMONARY CONDITIONS (Medical Condition) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 19.7% from 2023 to 2028 |
| Largest Segment | SERVICES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 2.2 (2023) |
| Revenue Forecast (Billions) | ~USD 5.4 (2028) |
| Segments Covered | Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028 |
UK Carrier Screening Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Products
- Services
By Type
- Customized Panel Testing
- Expanded Carrier Screening
- Predesigned Panel Testing
- Targeted Disease Carrier Screening
By Medical Condition
- Hematological Conditions
- Neurological Conditions
- Other Medical Conditions
- Pulmonary Conditions
By Technology
- Dna Microarrays
- Dna Sequencing
- Other Technologies
- Pcr
By End User
- Clinical Laboratories
- Fertility Clinics
- Hospitals And Medical Centers
- Other End Users
By Product & 2021-2028
- Products
- Services
UK: CARRIER SCREENING MARKET, BY END USER, 2021–2028
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 25.2 | 29.5 | 34.9 | 41.2 | 48.8 | 57.9 | 68.6 | 82.3 | 18.7 |
| FERTILITY CLINICS | 10.2 | 11.8 | 13.7 | 16 | 18.7 | 21.8 | 25.5 | 30 | 16.9 |
| HOSPITALS AND MEDICAL CENTERS | 59.7 | 70.8 | 84.8 | 101.6 | 121.8 | 146.2 | 175.6 | 213 | 20.2 |
| OTHER END USERS | 5.2 | 5.9 | 6.8 | 7.8 | 8.9 | 10.3 | 11.8 | 13.8 | 15.3 |
| TOTAL | 100.4 | 118.1 | 140.2 | 166.6 | 198.2 | 236.1 | 281.5 | 339 | 19.3 |
Target Audience
- Diagnostic Laboratory Operators : UK-based and international genetic testing laboratories need market data to assess growth opportunities, benchmark performance, and plan capacity expansion in the high-growth UK carrier screening segment.
- Healthcare Providers & NHS Trusts : Hospital networks, maternity services, and NHS commissioning bodies require insights into market trends and adoption patterns to optimize prenatal screening service offerings and procurement strategies.
- Medical Device & Biotech Companies : Manufacturers of sequencing platforms, genetic testing kits, and diagnostic tools need UK-specific market intelligence to guide product development, regulatory submissions, and commercial launch strategies.
- Investment & Private Equity Firms : Investors evaluating opportunities in UK healthcare diagnostics and genetic testing require detailed market forecasts, growth drivers, and competitive analysis to support due diligence and portfolio decisions.
- Healthcare Consultants & Strategy Firms : Management consultants advising healthcare organizations, insurers, and biotech companies need authoritative UK market data to develop evidence-based strategies and client recommendations.
Reasons to Buy this Report
- UK-Specific Market Sizing : Access precise valuation data for the UK carrier screening market with validated 2023 baseline (£140.2M) and 2028 forecast (£339.0M), enabling accurate business planning and investment decisions.
- NHS Integration Insights : Understand how NHS adoption patterns, commissioning decisions, and integration into prenatal pathways are reshaping the UK market landscape and creating opportunities for providers and suppliers.
- Competitive Landscape Analysis : Identify key UK diagnostic laboratories, genetic testing providers, and emerging players competing in the carrier screening space with region-specific competitive positioning.
- Regulatory & Policy Context : Gain clarity on UK regulatory frameworks, HFEA guidelines, and government health policies influencing carrier screening adoption, reimbursement, and market dynamics.
- Growth Driver Identification : Pinpoint the specific factors driving 19.3% CAGR in the UK—including technology adoption, awareness campaigns, and healthcare provider behavior—to inform strategic market entry and expansion strategies.
Frequently asked questions
What is the current size of the UK carrier screening market?
The UK carrier screening market was valued at £140.2 million in 2023 and is expected to grow to £339.0 million by 2028.
What is the projected growth rate for the UK carrier screening market?
The UK carrier screening market is projected to grow at a compound annual growth rate (CAGR) of 19.3% from 2023 to 2028.
What factors are driving growth in the UK carrier screening market?
Key drivers include NHS guideline expansion, advances in DNA sequencing technology, increased awareness of genetic disorders, and growing adoption of non-invasive prenatal testing across the UK.
How does the UK regulatory environment support carrier screening?
The UK benefits from strong regulatory oversight by the Human Fertilisation and Embryology Authority and NHS quality standards that ensure safe and effective carrier screening services.
What role does the NHS play in the UK carrier screening market?
The NHS provides integrated carrier screening services, establishes clinical guidelines, and ensures equitable access to genetic testing across the UK, significantly supporting market growth.
RESEARCH METHODOLOGY
The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.
Market Definition
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.
Market Stakeholders
- Carrier screening product manufacturers, vendors, and distributors
- Carrier screening service companies
- Hospitals and private physician clinics
- Reference laboratories
- Donor banks
- Health insurance payers
- Research & consulting firms
- Diagnostic Centers, and Medical Colleges
- Research Institutes
- Clinical Laboratories
- Distributors of Carrier Screening Products and services
Report Objectives
- To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
- Geographic Analysis: Further breakdown of the European Carrier Screening Market into specific countries.
Get the Full Carrier Screening Market Report
Full forecast, segment splits, and company analysis for all Carrier Screening Market.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
